Post-implant infections of pacemakers or defibrillators represent a significant complication, impacting patient morbidity and mortality. This case report describes a 75-year-old man with multiple comorbidities who developed pocket erosion of a previously implanted biventricular defibrillator, complicated by Staphylococcus Haemolyticus infection. Following device extraction and targeted antibiotic therapy, an extravascular implantable cardioverter defibrillator (EV-ICD) Aurora EV-ICD™ was implanted. The procedure was successfully performed, with a two-month follow-up showing no signs of infection or device displacement. EV-ICD emerges as a safe and effective alternative in high-risk patients, minimizing complications associated with vascular access and endocardial lead implantation.